41 related articles for article (PubMed ID: 19268418)
1. Computational designing of the ligands of Protein L affinity chromatography based on molecular docking and molecular dynamics simulations.
Rahmati S; Bagherzadeh K; Arab SS; Torkashvand F; Amanlou M; Vaziri B
J Biomol Struct Dyn; 2023 Oct; ():1-11. PubMed ID: 37855377
[TBL] [Abstract][Full Text] [Related]
2. On the interaction between protein L and immunoglobulins of various mammalian species.
De Château M; Nilson BH; Erntell M; Myhre E; Magnusson CG; Akerström B; Björck L
Scand J Immunol; 1993 Apr; 37(4):399-405. PubMed ID: 8469922
[TBL] [Abstract][Full Text] [Related]
3. Optimizing selectivity of anion hydrophobic multimodal chromatography for purification of a single-chain variable fragment.
Sakhnini LI; Pedersen AK; León IR; Greisen PJ; Hansen JJ; Vester-Christensen MB; Bülow L; Dainiak MB
Eng Life Sci; 2019 Jul; 19(7):490-501. PubMed ID: 32625026
[TBL] [Abstract][Full Text] [Related]
4. Exploration and Modulation of Antibody Fragment Biophysical Properties by Replacing the Framework Region Sequences.
Cnudde T; Lakhrif Z; Bourgoin J; Boursin F; Horiot C; Henriquet C; di Tommaso A; Juste MO; Jiacomini IG; Dimier-Poisson I; Pugnière M; Mévélec MN; Aubrey N
Antibodies (Basel); 2020 Apr; 9(2):. PubMed ID: 32326443
[TBL] [Abstract][Full Text] [Related]
5. Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential.
Karim-Silva S; Becker-Finco A; Jiacomini IG; Boursin F; Leroy A; Noiray M; de Moura J; Aubrey N; Billiald P; Alvarenga LM
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32316084
[TBL] [Abstract][Full Text] [Related]
6. Human IgA Monoclonal Antibodies That Neutralize Poliovirus, Produced by Hybridomas and Recombinant Expression.
Puligedda RD; Vigdorovich V; Kouiavskaia D; Kattala CD; Zhao JY; Al-Saleem FH; Chumakov K; Sather DN; Dessain SK
Antibodies (Basel); 2020 Feb; 9(1):. PubMed ID: 32121092
[TBL] [Abstract][Full Text] [Related]
7. Molecular Modeling of the Interaction of Protein L with Antibodies.
Paloni M; Cavallotti C
ACS Omega; 2017 Oct; 2(10):6464-6472. PubMed ID: 31457247
[TBL] [Abstract][Full Text] [Related]
8. Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks.
Lebozec K; Jandrot-Perrus M; Avenard G; Favre-Bulle O; Billiald P
MAbs; 2017; 9(6):945-958. PubMed ID: 28598281
[TBL] [Abstract][Full Text] [Related]
9. A method to confer Protein L binding ability to any antibody fragment.
Lakhrif Z; Pugnière M; Henriquet C; di Tommaso A; Dimier-Poisson I; Billiald P; Juste MO; Aubrey N
MAbs; 2016; 8(2):379-88. PubMed ID: 26683650
[TBL] [Abstract][Full Text] [Related]
10. Co-evolution of affinity and stability of grafted amyloid-motif domain antibodies.
Julian MC; Lee CC; Tiller KE; Rabia LA; Day EK; Schick AJ; Tessier PM
Protein Eng Des Sel; 2015 Oct; 28(10):339-50. PubMed ID: 26386257
[TBL] [Abstract][Full Text] [Related]
11. Creation of recombinant antigen-binding molecules derived from hybridomas secreting specific antibodies.
Fields C; O'Connell D; Xiao S; Lee GU; Billiald P; Muzard J
Nat Protoc; 2013 Jun; 8(6):1125-48. PubMed ID: 23680984
[TBL] [Abstract][Full Text] [Related]
12. Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom.
di Tommaso A; Juste MO; Martin-Eauclaire MF; Dimier-Poisson I; Billiald P; Aubrey N
J Biol Chem; 2012 Apr; 287(17):14149-56. PubMed ID: 22375011
[TBL] [Abstract][Full Text] [Related]
13. Cloning, expression and purification of Ppl-1, a kappa-chain binding protein, based upon protein L from Peptostreptococcus magnus.
Bottomley SP; Beckingham JA; Murphy JP; Atkinson M; Atkinson T; Hinton RJ; Gore MG
Bioseparation; 1995; 5(6):359-67. PubMed ID: 8767928
[TBL] [Abstract][Full Text] [Related]
14. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
15. Generation of a single-chain Fv fragment for the monitoring of deoxycholic acid residues anchored on endogenous proteins.
Kobayashi N; Ohtoyo M; Wada E; Kato Y; Mano N; Goto J
Steroids; 2005 Apr; 70(4):285-94. PubMed ID: 15784283
[TBL] [Abstract][Full Text] [Related]
16. Engineering antibodies for stability and efficient folding.
Honegger A
Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
[TBL] [Abstract][Full Text] [Related]
17. Applications of single-chain variable fragment antibodies in therapeutics and diagnostics.
Weisser NE; Hall JC
Biotechnol Adv; 2009; 27(4):502-20. PubMed ID: 19374944
[TBL] [Abstract][Full Text] [Related]
18. Grafting of protein L-binding activity onto recombinant antibody fragments.
Muzard J; Adi-Bessalem S; Juste M; Laraba-Djebari F; Aubrey N; Billiald P
Anal Biochem; 2009 May; 388(2):331-8. PubMed ID: 19268418
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
